skip to main content


Title: Excess mortality in the United States during the first three months of the COVID-19 pandemic
Abstract Deaths are frequently under-estimated during emergencies, times when accurate mortality estimates are crucial for emergency response. This study estimates excess all-cause, pneumonia and influenza mortality during the coronavirus disease 2019 (COVID-19) pandemic using the 11 September 2020 release of weekly mortality data from the United States (U.S.) Mortality Surveillance System (MSS) from 27 September 2015 to 9 May 2020, using semiparametric and conventional time-series models in 13 states with high reported COVID-19 deaths and apparently complete mortality data: California, Colorado, Connecticut, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Jersey, New York, Pennsylvania and Washington. We estimated greater excess mortality than official COVID-19 mortality in the U.S. (excess mortality 95% confidence interval (CI) 100 013–127 501 vs. 78 834 COVID-19 deaths) and 9 states: California (excess mortality 95% CI 3338–6344) vs. 2849 COVID-19 deaths); Connecticut (excess mortality 95% CI 3095–3952) vs. 2932 COVID-19 deaths); Illinois (95% CI 4646–6111) vs. 3525 COVID-19 deaths); Louisiana (excess mortality 95% CI 2341–3183 vs. 2267 COVID-19 deaths); Massachusetts (95% CI 5562–7201 vs. 5050 COVID-19 deaths); New Jersey (95% CI 13 170–16 058 vs. 10 465 COVID-19 deaths); New York (95% CI 32 538–39 960 vs. 26 584 COVID-19 deaths); and Pennsylvania (95% CI 5125–6560 vs. 3793 COVID-19 deaths). Conventional model results were consistent with semiparametric results but less precise. Significant excess pneumonia deaths were also found for all locations and we estimated hundreds of excess influenza deaths in New York. We find that official COVID-19 mortality substantially understates actual mortality, excess deaths cannot be explained entirely by official COVID-19 death counts. Mortality reporting lags appeared to worsen during the pandemic, when timeliness in surveillance systems was most crucial for improving pandemic response.  more » « less
Award ID(s):
1940179
NSF-PAR ID:
10297409
Author(s) / Creator(s):
; ;
Date Published:
Journal Name:
Epidemiology and Infection
Volume:
148
ISSN:
0950-2688
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Background Digital surveillance tools and health informatics show promise in counteracting diseases but have limited uptake. A notable illustration of the limits of such tools is the general failure of digital contact tracing in the United States in response to COVID-19. Objective We investigated the associations between individual characteristics and the willingness to use app-based contact tracing in Detroit, a majority-minority city that experienced multiple waves of COVID-19 outbreaks and deaths since the start of the pandemic. The aim of this study was to examine variations among residents in the willingness to download a contact tracing app on their phones to provide public health officials with information about close COVID-19 contact during summer 2020. Methods To examine residents’ willingness to participate in digital contact tracing, we analyzed data from 2 waves of the Detroit Metro Area Communities Study, a population-based survey of Detroit, Michigan residents. The data captured 1873 responses from 991 Detroit residents collected in June and July 2020. We estimated a series of multilevel logit models to gain insights into differences in the willingness to participate in digital contact tracing across a variety of individual attributes, including race/ethnicity, degree of trust in the government, and level of education, as well as interactions among these variables. Results Our results reflected widespread reluctance to participate in digital contact tracing in response to COVID-19, as less than half (826/1873, 44.1%) of the respondents said they would be willing to participate in app-based contact tracing. Compared to White respondents, Black (odds ratio [OR] 0.45, 95% CI 0.23-0.86) and Latino (OR 0.32, 95% CI 0.11-0.99) respondents were significantly less willing to participate in digital contact tracing. Trust in the government was positively associated with the willingness to participate in digital contact tracing (OR 1.17, 95% CI 1.07-1.27), but this effect was the strongest for White residents (OR 2.14, 95% CI 1.55-2.93). We found similarly divergent patterns of the effects of education by race. While there were no significant differences among noncollege-educated residents, White college-educated residents showed greater willingness to use app-based contact tracing (OR 6.12, 95% CI 1.86-20.15) and Black college-educated residents showed less willingness (OR 0.46, 95% CI 0.26-0.81). Conclusions Trust in the government and education contribute to Detroit residents’ wariness of digital contact tracing, reflecting concerns about surveillance that cut across race but likely arise from different sources. These findings point to the importance of a culturally informed understanding of health hesitancy for future efforts hoping to leverage digital contact tracing. Though contact tracing technologies have the potential to advance public health, unequal uptake may exacerbate disparate impacts of health crises. 
    more » « less
  2. This dataset lists 289 blacklegged tick population datasets from 6 studies that record abundance. These datasets were found by inputing keywords Ixodes Scapularis and tick in data repositories including Long Term Ecological Research data portal, National Ecological Observatory Network data portal, Google Datasets, Data Dryad, and Data One. The types of tick data recorded from these studies include density (number per square meter for example), proportion of ticks, count of ticks found on people. The locations of the datasets range from New York, New Jersey, Iowa, Massachusetts, and Connecticut, and range from 9 to 24 years in length. These datasets vary in that some record different life stages, geographic scope (county/town/plot), sampling technique (dragging/surveying), and different study length. The impact of these study factors on study results is analyzed in our research.

    Funding:

    RMC is supported by the National Institute of General Medical Sciences of the National Institutes of the Health under Award Number R25GM122672. CAB, JP, and KSW are supported by the Office of Advanced Cyberinfrastructure in the National Science Foundation under Award Number #1838807. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.

    {"references": ["Ellison A. 2017. Incidence of Ticks and Tick Bites at Harvard Forest since 2006. Environmental Data Initiative. https://doi.org/10.6073/pasta/71f12a4ffb7658e71a010866d1805a84. Dataset accessed 6/25/2019", "New York State Department of Health Office of Public Health. 2019. Deer Tick Surveillance: Adults (Oct to Dec) excluding Powassan virus: Beginning 2008. https://health.data.ny.gov/Health/Deer-Tick-Surveillance-Nymphs-May-to-Sept-excludin/kibp-u2ip", "New York State Department of Health Office of Public Health. 2019. Access Nymph Deer Tick Collection Data by County (Excluding Powassan Virus). https://health.data.ny.gov/Health/Deer-Tick-Surveillance-Nymphs-May-to-Sept-excludin/kibp-u2ip", "Ostfeld RS, Levi T, Keesing F, Oggenfuss K, Canham CD (2018) Data from: Tick-borne disease risk in a forest food web. Dryad Digital Repository. https://doi.org/10.5061/dryad.d1c8046", "Oliver JD, Bennett SW, Beati L, Bartholomay LC (2017) Range Expansion and Increasing Borrelia burgdorferi Infection of the Tick Ixodes scapularis (Acari: Ixodidae) in Iowa, 1990\u20132013. Journal of Medical Entomology 54(6): 1727-1734. https://doi.org/10.1093/jme/tjx121", "The Connecticut Agricultural Experiment Station. (n.d.). Summaries of tick testing. CT.gov. Retrieved May 12, 2022, from https://portal.ct.gov/CAES/Fact-Sheets/Tick-Summary/Summaries-of-Tick-Testing", "Jordan, R. A., & Egizi, A. (2019). The growing importance of lone star ticks in a Lyme disease endemic county: Passive tick surveillance in Monmouth County, NJ, 2006 - 2016. PloS one, 14(2), e0211778. https://doi.org/10.1371/journal.pone.0211778"]} 
    more » « less
  3. null (Ed.)
    Rationale To understand novel diseases, patients may draw comparisons to other diseases. Objective We examined whether mentally associating specific diseases with COVID-19 was related to self-reported protective behaviors early in the pandemic. Methods In March 2020, a national sample of 6534 U.S. adults listed diseases that came to mind when thinking of COVID-19. They self-reported protective behaviors, demographics, and COVID-19 risk perceptions. Results Participants associated COVID-19 with common infectious diseases like seasonal influenza (59%), common cold (11%), and pneumonia (10%), or emergent infectious diseases like pandemic influenza (28%), SARS/MERS (27%), and Ebola (14%). Seasonal influenza was most commonly mentioned, in all demographic groups. Participants mentioning seasonal influenza or common cold reported fewer protective behaviors. Those mentioning pneumonia or emergent infectious diseases reported more protective behaviors. Mentioning pneumonia, SARS/MERS, and Ebola was associated with the most protective behaviors, after accounting for other generated diseases, demographics, and risk perceptions (e.g., for avoiding crowds, OR = 1.52, 95% CI = 1.26, 1.83; OR = 1.28, 95% CI = 1.13, 1.46; OR = 1.30, 95% CI = 1.11, 1.52, respectively). Conclusions Early in the pandemic, most participants mentally associated COVID-19 with seasonal flu, which may have undermined willingness to protect themselves. To motivate behavior change, COVID-19 risk communications may need to mention diseases that resonate with people while retaining accuracy. 
    more » « less
  4. null (Ed.)
    Abstract We use COVID-19 case and mortality data from 1 February 2020 to 21 September 2020 and a deterministic SEIR (susceptible, exposed, infectious and recovered) compartmental framework to model possible trajectories of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the effects of non-pharmaceutical interventions in the United States at the state level from 22 September 2020 through 28 February 2021. Using this SEIR model, and projections of critical driving covariates (pneumonia seasonality, mobility, testing rates and mask use per capita), we assessed scenarios of social distancing mandates and levels of mask use. Projections of current non-pharmaceutical intervention strategies by state—with social distancing mandates reinstated when a threshold of 8 deaths per million population is exceeded (reference scenario)—suggest that, cumulatively, 511,373 (469,578–578,347) lives could be lost to COVID-19 across the United States by 28 February 2021. We find that achieving universal mask use (95% mask use in public) could be sufficient to ameliorate the worst effects of epidemic resurgences in many states. Universal mask use could save an additional 129,574 (85,284–170,867) lives from September 22, 2020 through the end of February 2021, or an additional 95,814 (60,731–133,077) lives assuming a lesser adoption of mask wearing (85%), when compared to the reference scenario. 
    more » « less
  5. Abstract Background

    The Mexican Institute of Social Security (IMSS) is the largest health care provider in Mexico, covering about 48% of the Mexican population. In this report, we describe the epidemiological patterns related to confirmed cases, hospitalizations, intubations, and in-hospital mortality due to COVID-19 and associated factors, during five epidemic waves recorded in the IMSS surveillance system.

    Methods

    We analyzed COVID-19 laboratory-confirmed cases from the Online Epidemiological Surveillance System (SINOLAVE) from March 29th, 2020, to August 27th, 2022. We constructed weekly epidemic curves describing temporal patterns of confirmed cases and hospitalizations by age, gender, and wave. We also estimated hospitalization, intubation, and hospital case fatality rates. The mean days of in-hospital stay and hospital admission delay were calculated across five pandemic waves. Logistic regression models were employed to assess the association between demographic factors, comorbidities, wave, and vaccination and the risk of severe disease and in-hospital death.

    Results

    A total of 3,396,375 laboratory-confirmed COVID-19 cases were recorded across the five waves. The introduction of rapid antigen testing at the end of 2020 increased detection and modified epidemiological estimates. Overall, 11% (95% CI 10.9, 11.1) of confirmed cases were hospitalized, 20.6% (95% CI 20.5, 20.7) of the hospitalized cases were intubated, and the hospital case fatality rate was 45.1% (95% CI 44.9, 45.3). The mean in-hospital stay was 9.11 days, and patients were admitted on average 5.07 days after symptoms onset. The most recent waves dominated by the Omicron variant had the highest incidence. Hospitalization, intubation, and mean hospitalization days decreased during subsequent waves. The in-hospital case fatality rate fluctuated across waves, reaching its highest value during the second wave in winter 2020. A notable decrease in hospitalization was observed primarily among individuals ≥ 60 years. The risk of severe disease and death was positively associated with comorbidities, age, and male gender; and declined with later waves and vaccination status.

    Conclusion

    During the five pandemic waves, we observed an increase in the number of cases and a reduction in severity metrics. During the first three waves, the high in-hospital fatality rate was associated with hospitalization practices for critical patients with comorbidities.

     
    more » « less